AROMASIN may that breast cancer and repetition

AROMASIN pills
Photo ? Karl Stephan

AROMASIN (Exemestane) can prevent that new cases of breast cancer, as well as repetition in post-menopausal women. ? you also know that Exemestane can soon in generic form available like, such as the patent in April expired, 1. ?, which would make for a less expensive drug that reduces the number of newly diagnosed breast cancers.

This message is the result of a study of NCIC clinical trials group at Queen's University in Ontario, Canada. ? presented the results of the study this year were the American Society of Clinical Oncology meeting in Chicago. In the New England Journal of Medicine published a study that ran for 5 years and contain more than 4,500 women And? France, life in the United States, Spain,. ? women in this study were already menopausal and were identified as high risk for breast cancer.

This is not the first time, a hormone therapy considered ? tamoxifen widely for many pre Chemoprevention for breast cancer. required- and post-menopausal women after treatment for estrogen sensitive breast tissue cancer. ? it prevents that the return of breast cancer by blocking estrogen receptors, but it estrogen production. ? that down not, stops to tamoxifen and the reason that many patients do not take it for the full five years, is the standard combination, it caused the side effects. ? tamoxifen menopause-like hot flashes, night sweats and increases the risk of endometrial cancer, cataract, and stroke.

AROMASIN has milder side effects than tamoxifen and differently. works tamoxifen ? blocks estrogen and AROMASIN prevents estrogen ? AROMASIN is production an aromatase inhibitor, often given is post-menopausal breast cancer patients who have completed treatment for estrogen sensitive breast tissue cancer. ?, neither drug, patients benefit the estrogen receptor would have negative breast tumors, such as triple negative breast cancer (TNBC).

Not you and questions hurry you your doctor, just yet. ? to prescribe Exemestane as breast cancer prevention, which prevents more studies on its benefits and risks, as well as its effectiveness in the development of breast cancer in high-risk women need to be performed. ? But if the research holds, this drug can it that many preemptive genetic testing had mastectomies in young and old women, and were a strong family history and a genetic predisposition for breast cancer. ? for women, the an early case which accounts for hot flashes, to a breast tumor that was to avoid side effects of Exemestane seem not too bad.

View the original article here